Healthcare marketing with AI: Drug-GPT and Audience Analyzer

The evolution of healthcare marketing is being rewritten by the innovative use of Artificial Intelligence (AI), particularly with solutions like Drug-GPT at the forefront. Today’s healthcare Strategists face the complex challenge of interpreting an ever-growing chorus of voices from Patients, healthcare professionals (HCPs), and Influencers. Drug-GPT is the game-changer, offering a strategic toolkit to not just listen, but understand and strategically act on the diverse narratives within the healthcare sphere. 

Understanding the Audience: The Power of the Audience Analyzer  

The Audience Analyzer goes beyond traditional data analysis by employing Advanced Multi-Level Sentiment and Topic models, giving strategists a 360° view of defined subpopulations. This analyzer empowers users to gain an in-depth overview of their audience through intricate data visualizations, succinct text summaries, and insightful natural language answers. It is not about data for data’s sake; it is about converting complex information into a clear, visual narrative that strategists can use to make informed decisions. 

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams. The Talking Medicines mission is to be the World’s Gold Standard for Patient Intelligence by Medicine.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
Tern plc

More articles like this

Tern plc

How AI-human synergy is rewriting the rules of Pharma Marketing

AI is no longer a futuristic concept in Pharma Marketing—it’s a powerful force already reshaping strategy, precision, and personalisation at scale. But its real magic happens when it partners with human expertise, unlocking smarter, more responsive

Tern plc

Tern advancing innovation in IoT and AI

Tern drives innovation in IoT and AI sectors through strategic investments and collaborations, showcasing its strong momentum in disruptive technologies.